AssetMark’s IDEAYA Biosciences IDYA Stock Holding History
Bought
Maintained
Sold
Other funds holding IDYA
AssetMark's IDYA Position: Q3 2026 in Review
AssetMark reduced its IDEAYA Biosciences (IDYA) stake by 2.6% in Q3 2026, selling an estimated $64.5K and leaving 63,313 shares worth $2.43M. The position accounts for ﹤0.01% of the portfolio, ranked #902.
AssetMark first reported a position in IDYA in Q1 2024 and has held it in 11 quarters since. The position peaked at $2.49M in Q4 2025. 204 funds tracked by Wall St. Rank hold IDYA as of Q3 2026.
- AssetMark held 63,313 shares of IDEAYA Biosciences worth $2.43M as of Q3 2026.
- AssetMark sold 1,708 IDEAYA Biosciences shares in Q3 2026, an estimated $64.5K.
- IDEAYA Biosciences made up ﹤0.01% of AssetMark's portfolio in Q3 2026, its #902 holding.
- AssetMark first reported a position in IDEAYA Biosciences in Q1 2024 and has held it in 11 quarters since.
- AssetMark's IDEAYA Biosciences position peaked at $2.49M in Q4 2025.
- 204 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q3 2026.
Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.